Seventy-five STEMI patients who had received emergency reperfusion therapy were enrolled and randomized into the hydrophilic statin group ( rosuvastatin ; @ mg/day , n = @ ) and hydrophobic statin group ( atorvastatin ; @ mg/day , n = @ ) for @ months .